Development of WHO Biological Reference Preparations for Blood Safety-related in vitro Diagnostic Tests
Report of the 2nd meeting with the WHO Collaborating Centres for Biological Standards and Standardization, 17-18 February 2009
Overview
The Blood Products and Related Biologicals programme in the Quality and Safety of Medicines team (QSM), Department of Essential Medicines and Pharmaceutical Policies (EMP), World Health Organization (WHO) convened the 2nd meeting with the WHO Collaborating Centres for Biological Standards and Standardization (WHO CCs), i.e. the National Institute of Biological Standards and Control (NIBSC), UK, the Paul-Ehrlich-Institute (PEI), Germany, and the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), USA. The meeting was kindly hosted, from 17 to 18 February 2009, by the Paul-Ehrlich-Institute in Langen, Germany